Diseases Market Research Reports

Medical Diseases Market Research Reports, Analysis & Trends

 
Publication Single User License (PDF) Price
MT-2 Melatonin Receptor Agonists -Pipeline Insights, 2015

MT-2 Melatonin Receptor Agonists -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, MT-2 Melatonin Receptor Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the MT-2 Melatonin Receptor Agonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The MT-2 Melatonin Receptor Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Diabetic Gastroparesis-Pipeline Insights, 2015

Diabetic Gastroparesis-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Diabetic Gastroparesis- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Diabetic Gastroparesis. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Diabetic Gastroparesis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Rubella-Pipeline Insights, 2015

Rubella-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Rubella- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Rubella. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Rubella Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
GABA Receptor Modulators -Pipeline Insights, 2015

GABA Receptor Modulators -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, GABA Receptor Modulators- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the GABA Receptor Modulators. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The GABA Receptor Modulators Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Acute Renal Failure (ARF) (Acute Kidney Injury)-Pipeline Insights, 2015

Acute Renal Failure (ARF) (Acute Kidney Injury)-Pipeline Insights, 2015

Date Published: May 14 2015

Summary

$1,250.00
Yes Tyrosine Kinase Inhibitors -Pipeline Insights, 2015

Yes Tyrosine Kinase Inhibitors -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Yes Tyrosine Kinase Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Yes Tyrosine Kinase Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Yes Tyrosine Kinase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Myelofibrosis-Pipeline Insights, 2015

Myelofibrosis-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Myelofibrosis- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Myelofibrosis. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Myelofibrosis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Bone Morphogenetic Protein (BMP) Receptor Activators -Pipeline Insights, 2015

Bone Morphogenetic Protein (BMP) Receptor Activators -Pipeline Insights, 2015

Date Published: May 14 2015

Summary

$1,250.00
Plasminogen Activator Inhibitors-1 (PAI-1) -Pipeline Insights, 2015

Plasminogen Activator Inhibitors-1 (PAI-1) -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Plasminogen Activator Inhibitors-1 (PAI-1)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Plasminogen Activator Inhibitors-1 (PAI-1). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Plasminogen Activator Inhibitors-1 (PAI-1) Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Guillain-Barre Syndrome-Pipeline Insights, 2015

Guillain-Barre Syndrome-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Guillain-Barre Syndrome- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Guillain-Barre Syndrome. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Guillain-Barre Syndrome Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Venous Thromboembolism-Pipeline Insights, 2015

Venous Thromboembolism-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Venous Thromboembolism- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Venous Thromboembolism. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Venous Thromboembolism Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Interleukin-17 (IL-17) Inhibitors -Pipeline Insights, 2015

Interleukin-17 (IL-17) Inhibitors -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Interleukin-17 (IL-17) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Interleukin-17 (IL-17) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Interleukin-17 (IL-17) Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Celiac Disease-Pipeline Insights, 2015

Celiac Disease-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Celiac Disease- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Celiac Disease. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Celiac Disease Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Post Operative Nausea And Vomiting-Pipeline Insights, 2015

Post Operative Nausea And Vomiting-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Post Operative Nausea And Vomiting- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Post Operative Nausea And Vomiting. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Post Operative Nausea And Vomiting Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
DNA Primase Inhibitors -Pipeline Insights, 2015

DNA Primase Inhibitors -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, DNA Primase Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the DNA Primase Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The DNA Primase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Thioredoxin Reductase Inhibitors -Pipeline Insights, 2015

Thioredoxin Reductase Inhibitors -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Thioredoxin Reductase Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Thioredoxin Reductase Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Thioredoxin Reductase Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Liver Cirrhosis-Pipeline Insights, 2015

Liver Cirrhosis-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Liver Cirrhosis- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Liver Cirrhosis. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Liver Cirrhosis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Angiopoietin 1 (Ang-1) Inhibitors -Pipeline Insights, 2015

Angiopoietin 1 (Ang-1) Inhibitors -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Angiopoietin 1 (Ang-1) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Angiopoietin 1 (Ang-1) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Angiopoietin 1 (Ang-1) Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Neuropeptide Y Receptor Y5 (NPY5R) Antagonists -Pipeline Insights, 2015

Neuropeptide Y Receptor Y5 (NPY5R) Antagonists -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Neuropeptide Y Receptor Y5 (NPY5R) Antagonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Neuropeptide Y Receptor Y5 (NPY5R) Antagonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Neuropeptide Y Receptor Y5 (NPY5R) Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Enterovirus Infections-Pipeline Insights, 2015

Enterovirus Infections-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Enterovirus Infections- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Enterovirus Infections. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Enterovirus Infections Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data